Important therapies for the future of immunotherapy

<p style="font-weight: 400;">This is the latest episode of the free DDW narrated podcast, “Important therapies for the future of immunotherapy", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “<a href= "https://www.ddw-online.com/improving-quality-control-for-car-t-cell-therapies-18259-202208/" target="_blank" rel="noopener">Improving quality control for CAR T cell therapies</a>”, and “<a href= "https://www.ddw-online.com/the-importance-of-lag-3-to-the-future-of-immunotherapy-26739-202207/" target="_blank" rel="noopener">The importance of LAG-3 to the future of immunotherapy</a>”.</p> <p>The first article includes insight from Mark White, Associate Director of Biopharma Product Marketing at Bio-Rad and Marwan Alsarraj, Biopharma Segment Manager, Digital Biology Group. The second article is an interview between Lu Rahman and Frederic Triebel, CSO, Immutep, who also discovered LAG-3.</p>